ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FUM Futura Medical Plc

40.50
1.70 (4.38%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.70 4.38% 40.50 39.70 40.50 40.00 39.00 39.60 359,491 16:35:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -20.62 120.28M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 38.80p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £120.28 million. Futura Medical has a price to earnings ratio (PE ratio) of -20.62.

Futura Medical Share Discussion Threads

Showing 16226 to 16235 of 21225 messages
Chat Pages: Latest  657  656  655  654  653  652  651  650  649  648  647  646  Older
DateSubjectAuthorDiscuss
25/1/2023
19:21
Petroc, I am seeing this kind of behaviour across a range of stocks, where posters with no disclosed position repetitively rubbish companies, clearly with the motive of short selling or otherwise trying to drive the price down. Some of these vermin may be in the pay of large hedge funds who will stoop to anything to make money.
wheeze
25/1/2023
19:07
Arousal gel is also a ‘topically applied gel which utilises’ the same ingredients as Med3000. Arousal gels too have ‘the potential to be a highly differentiated product by addressing significant unmet needs in the ED market’




Ingredients

Water, ethanol (35%), propylene glycol, glycerin, carbomer, potassium hydroxide.







water-based warming gel

Ingredients Stimulant Gel Aqua, Glycerin, Propylene Glycol, Alcohol Denat, Carbomer

lbo
25/1/2023
17:37
Still waiting for a scientific substantiation with non deficient evidence how 2 gels with the same ingredients can be giving different results?



Ingredients Water, ethanol (35%), propylene glycol, glycerin, carbomer, potassium hydroxide.





water-based warming gel Ingredients

Stimulant Gel Aqua, Glycerin, Propylene Glycol, Alcohol Denat, Carbomer

lbo
25/1/2023
17:15
Wheeze, you're absolutely right about LiarBO, but you probably should filter me as well, as I'm only here to post the opposite of what the lying stock basher posts.
petroc
25/1/2023
17:13
Poor old LiarBO! Sitting at his keyboard, hour after hour, desperately bashing a stock in which he has no financial interest. Well, no holding, anyway. His only financial interest is all the money he lost when he invested more than he could afford in CSD500 and lost the lot through naive investing. The silly beggar used to post on all sorts of threads here before he lost all his money, then suddenly CSD500 failed and LiarBO stopped all the other threads to concentrate on bashing FUM, presumably out of some twisted revenge strategy. 5 years he's been doing it! What a sad loser!
petroc
25/1/2023
17:12
Hahaha! That's one of your funniest posts yet, and I'm. Not even talking about. Your childish use of full. Stops in the middle of sentences! What a loser you are, LiarBO!
petroc
25/1/2023
17:11
LBO - spam poster.

Filtered.

wheeze
25/1/2023
16:56
The ramper is also now claiming if anyone including the EU has no financial interest/shareholding. They should just turn a blind eye and allow consumers to be misled by medical device claims that cannot be substantiated. And also according to the ramper consumers should have no rights to be fully informed or to seek redress for being misled!


‘You have the right to seek redress if you are treated unfairly’

Misleading and aggressive practices

giving false information) or omission (leaving out important information) aggressive practices

Like the rampers posting all tests were passed with flying colours yet always omitting to post that the tests were also alll deficient as they were unblinded and uncontrolled



Assessment

Upheld

The ASA noted that the product appeared to meet the requirements of the Medical Device Directive (MDD) but understood that the MDD did not harmonise EU law relating the advertising of medical devices, which was subject to Directive 2005/29/EC on unfair business to consumer commercial practices (including advertising) generally (Unfair commercial practices directive - UCPD). That meant that advertisers must still meet the requirements of the CAP Code, which reflected the provisions of UCPD. Under the CAP and BCAP Codes, medical claims could be made for CE-marked medical devices provided they complied with other requirements of the Codes, including those relating to substantiation.

CE certification in itself does not constitute evidence for medical efficacy claims, and advertisers need to ensure that they hold evidence for such claims.

There was no statistically significant difference between the outcomes for the treatment group (patients using the Aerosure device) and the control group (using an inactive sham device). The study was accordingly not adequate evidence of the efficacy




Because the trial was not placebo-controlled, we considered AcceleDent had not provided adequate evidence to support the claim AcceleDent, is also clinically proven to reduce the pain and discomfort associated with braces and aligners by up to 71%. We concluded that the claim had not been substantiated and was misleading.

On that point the claim breached CAP Code (Edition 12) rules 3.1 (Misleading advertising), 3.7 (Substantiation) and 12.1 Medicines, medical devices, health-related products and beauty products.



Assessment

Upheld

The ASA noted that the product appeared to meet the requirements of the Medical Device Directive (MDD) but understood that the MDD did not harmonise EU law relating the advertising of medical devices, which was subject to Directive 2005/29/EC on unfair business to consumer commercial practices (including advertising) generally (Unfair commercial practices directive - UCPD). That meant that advertisers must still meet the requirements of the CAP Code, which reflected the provisions of UCPD. Under the CAP and BCAP Codes, medical claims could be made for CE-marked medical devices provided they complied with other requirements of the Codes, including those relating to substantiation.

CE certification in itself does not constitute evidence for medical efficacy claims, and advertisers need to ensure that they hold evidence for such claims.

There was no statistically significant difference between the outcomes for the treatment group (patients using the Aerosure device) and the control group (using an inactive sham device). The study was accordingly not adequate evidence of the efficacy

lbo
25/1/2023
16:37
Poor old LiarBO! Sitting at his keyboard, hour after hour, desperately bashing a stock in which he has no financial interest. Well, no holding, anyway. His only financial interest is all the money he lost when he invested more than he could afford in CSD500 and lost the lot through naive investing. The silly beggar used to post on all sorts of threads here before he lost all his money, then suddenly CSD500 failed and LiarBO stopped all the other threads to concentrate on bashing FUM, presumably out of some twisted revenge strategy. 5 years he's been doing it! What a sad loser!
petroc
25/1/2023
16:16
Its all bias and fraud with the ramper unsubstantiated claims that there is any non deficient evidence to substantiate Med3000 is having an effect beyond what a similar placebo arousal gel made of the same ingredients would have in those tests.



Erectile function was significantly improved among participants in the placebo arm,

Placebo effect size was larger among participants with ED associated with posttraumatic stress disorder



Bias and Fraud

There are numerous biases in medical research that render evidence from such research systematically misleading. Some of these biases are exacerbated by conflicts of interest, including fantastic financial incentives. The most important biases in medical research include confirmation bias, design bias, analysis bias, and publication bias. Arguably, some forms of bias, such as publication bias, should be considered as fraud. The pervasiveness of bias in medical research justifies one of the premises of the master argument for medical nihilism. Medical research is malleable due to the many biases, and such malleability allows for the production of evidence that suggests medical interventions are effective, whether or not they are in fact effective.



What method-issues to consider when assessing Risk of Bias
Concealment of randomization
Those enrolling patients are aware of the group (or period in a cross-over trial) to which the next enrolled patient will be allocated (major problem in pseudo or quasi randomized trials with allocation by day of week, birth date, chart number etc.)

Blinding
Patient, caregivers, those recording outcomes, those adjudicating outcomes, or data analysts are aware of the arm to which patients are allocated (or the medication currently being received in a cross-over trial)

Loss to follow-up
Loss to follow-up and failure to adhere to the intention to treat principle in superiority trials; or, in non-inferiority trials, loss to follow-up and failure to conduct both analyses considering only those who adhered to treatment, and all patients for whom outcome data are available

Selective outcome reporting
Incomplete or absent reporting of some outcomes and not others on the basis of the results

Use of unvalidated outcome measures (e.g., patient-reported outcomes)

lbo
Chat Pages: Latest  657  656  655  654  653  652  651  650  649  648  647  646  Older

Your Recent History

Delayed Upgrade Clock